
A common fruit fly, scientifically known as drosophila melanogaster, is pictured on the tip of a small brush in a micro-view photograph made in the research lab of Genetics Professor Barry Ganetzky at the Genetics-Biotechnology Center Building at the University of Wisconsin-Madison on Jan. 17, 2012. Ganetzky, a geneticist and Steenbock Professor of Biological Sciences, is one of several UW-Madison researchers who study the genetic development of the common fruit fly. (Photo by Jeff Miller/UW-Madison)
In an era of widespread genetic sequencing, the ability to edit and alter an organism’s DNA is a powerful way to explore the information within and how it guides biological function.
A paper from the University of Wisconsin-Madison in the August issue of the journal GENETICS takes genome editing to a new level in fruit flies, demonstrating a remarkable level of fine control and, importantly, the transmission of those engineered genetic changes across generations.
Both features are key for driving the utility and spread of an approach that promises to give researchers new insights into the basic workings of biological systems, including embryonic development, nervous system function, and the understanding of human disease.
“Genome engineering allows you to change gene function in a very targeted way, so you can probe function at a level of detail” that wasn’t previously possible, says Melissa Harrison, an assistant professor of biomolecular chemistry in the UW-Madison School of Medicine and Public Health and one of the three senior authors of the new study.
Disrupting individual genes has long been used as a way to study their roles in biological function and disease. The new approach, based on molecules that drive a type of bacterial immune response, provides a technical advance that allows scientists to readily engineer genetic sequences in very detailed ways, including adding or removing short bits of DNA in chosen locations, introducing specific mutations, adding trackable tags, or changing the sequences that regulate when or where a gene is active.
The approach used in the new study, called the CRISPR RNA/Cas9 system, has developed unusually fast. First reported just one year ago by scientists at the Howard Hughes Medical Institute and University of California, Berkeley, it has already been applied to most traditional biological model systems, including yeast, zebrafish, mice, the nematode C. elegans, and human cells. The Wisconsin paper was the first to describe it in fruit flies and to show that the resulting genetic changes could be passed from one generation to the next.
“There was a need in the community to have a technique that you could use to generate targeted mutations,” says Jill Wildonger, a UW-Madison assistant professor of biochemistry and another senior author of the paper. “The need was there and this was the technical advance that everyone had been waiting for.”
“The reason this has progressed so quickly is that many researchers — us included — were working on other, more complicated, approaches to do exactly the same thing when this came out,” adds genetics assistant professor Kate O’Connor-Giles, the third senior author. “This is invaluable for anyone wanting to study gene function in any organism and it is also likely to be transferable to the clinical realm and gene therapy.”
The CRISPR RNA/Cas9 system directs a DNA-clipping enzyme called Cas9 to snip the DNA at a targeted sequence. This cut then stimulates the cell’s existing DNA repair machinery to fill in the break while integrating the desired genetic tweaks. The process can be tailored to edit down to the level of a single base pair — the rough equivalent of changing a single letter in a document with a word processor.
The broad applicability of the system is aided by a relatively simple design that can be customized through creation of a short RNA sequence to target a specific sequence in the genome to generate the desired changes. Previous genome editing methods have relied on making custom proteins, which is costly and slow.
“This is so readily transferable that it’s highly likely to enable gene knockout and other genome modifications in any organism,” including those that have not previously been used for laboratory work, says O’Connor-Giles. “It’s going to turn non-model organisms into genetic model organisms.”
That ease may also pay off in the clinic. “It can be very difficult and time-consuming to generate models to study all the gene variants associated with human diseases,” says Wildonger. “With this genome editing approach, if we work in collaboration with a clinician to find [clinically relevant] mutations, we can rapidly translate these into a fruit fly model to see what’s happening at the cellular and molecular level.”
The Latest Bing News on:
Genome editing
- Genome editing delays ageing in miceon January 25, 2021 at 8:04 am
Recently, scientists at the Chinese Academy of Sciences in Beijing, China, investigated novel drivers of senescence to try and delay ageing in mice. 'These mice show after six to eight months overall ...
- Spotting Every Needle in the Haystack: CRISPeR Gene Editing for DNA with Lone Mutationson January 25, 2021 at 5:36 am
The quest to change the very nature of being, has driven philosophical and metaphysical debates for ages. Now, with the advent of ...
- Microbiosci Launches Complete Solutions for Genome Editing with CRISPR Technologyon January 22, 2021 at 4:06 pm
Microbiosci announced the release of its one-stop CRISPR /Cas9-mediated Genome Editing Service that can be applied in the process of genome editing. New York, USA - January 22, 2021 - Microbiosci, ...
- Killing cancer by stealth: Gene editing firm Precision Bio secures another FDA approval to advance drugson January 22, 2021 at 12:10 pm
The Durham clinical-stage biotechnology company has received U.S. Food and Drug Administration approval to advance its new drug for patients with relapsed/refractory non-Hodgkin Lymphoma.
- Researcher expands plant genome editing with newly engineered variant of CRISPR-Cas9on January 22, 2021 at 9:46 am
Alongside Dennis van Engelsdorp, associate professor at the University of Maryland (UMD) in Entomology named for the fifth year in a row for his work in honey bee and pollinator health, Yiping Qi, ...
- UMD researcher expands plant genome editing with newly engineered variant of CRISPR-Cas9on January 22, 2021 at 8:25 am
Recently named a Web of Science 2020 Highly Cited Researcher, Yiping Qi of the University of Maryland already has a new high-profile publication in 2021 introducing SpRY, a newly engineered variant of ...
- Gene Editing Technique Halts Premature Aging In Miceon January 21, 2021 at 12:41 pm
A specialized gene editing technique that allows very small and precise changes to be made to the genetic code can halt a disease that causes premature aging in a mouse model and double the lifespan ...
- Plant genome editing expanded with newly engineered variant of CRISPR-Cas9on January 20, 2021 at 4:00 pm
Scientists have created a newly engineered variant of the famed gene editing tool CRISPR-Cas9. SpRY removes the barriers of what can and can't be targeted for gene editing, making it possible for the ...
- Gene editing shows potential to correct mutations causing inherited retinal degenerationon January 20, 2021 at 5:11 am
Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness.
- Genome editing to treat human retinal degenerationon January 19, 2021 at 1:57 pm
Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and str ...
The Latest Google Headlines on:
Genome editing
The Latest Bing News on:
CRISPR RNA/Cas9
- Feed has no items.